Tracking new bladder cancer treatment in everyday practice
NCT ID NCT07309445
Summary
This study follows 150 people with early-stage bladder cancer who have already started treatment with TAR-200 in real-world medical settings. The main goal is to see how long patients stay cancer-free after starting this treatment and to monitor how the treatment is actually used by doctors and patients outside of strict clinical trials. Researchers will track whether the cancer returns, worsens, or requires additional treatments over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-MUSCLE INVASIVE BLADDER NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Arkansas Urology
RECRUITINGLittle Rock, Arkansas, 72211, United States
Conditions
Explore the condition pages connected to this study.